eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®

Press/Media: Research

Description

Extension to proven TriMix® adjuvant technology intended to boost dendritic cell activation

Period23 Jun 2021

Media contributions

1

Media contributions

Keywords

  • mRNA
  • dendritic cell
  • cancer
  • immunotherapy